This 2016 narrative review by Distrutti et al., published in the World Journal of Gastroenterology, examines the role of gut microbiota in the pathogenesis and treatment of irritable bowel syndrome (IBS). The authors discuss how alterations in gut microbiota composition—such as reduced levels of beneficial bacteria like Lactobacilli and Bifidobacteria
